ACTINI SAS is a French company specializing in designing, building, and marketing continuous pasteurization and sterilization equipment for liquid treatment. With 70 years of experience, the company has developed patented technologies to focus on two specialized markets: decontamination of effluents for laboratories and biopharmaceutical factories, as well as the transformation of liquid or powdered egg products. Despite this specialization, ACTINI continues to provide pasteurizers and mini-lines for milk, juices, and fruit purees processing.
Its ability to innovate, technical expertise, and historical know-how have allowed the company to offer increasingly innovative solutions to fulfill the primary functions of its machines, including pasteurizing, sterilizing, and decontaminating, while addressing current challenges related to productivity, profitability, and environmental preservation.
The company's objective is to support its clients from the initial stages of project planning to operational phases, ensuring attentive support, rigorous implementation, reliable control tools, efficient training and maintenance services, as well as financing assistance, regardless of their location.
ACTINI SAS operates in industries such as biopharma, food and beverage, manufacturing, and nutrition. With its headquarters in France and a foundation dating back to 1953, the company stands out for its long-standing expertise and specialized focus in the liquid treatment equipment market.
Currently, there is no publicly available information about the last investment or the investors involved.
There is no investment information
No recent news or press coverage available for ACTINI SAS.